Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rocket science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines for severe community-acquired pneumonia.
Charles PG, Davis JS, Grayson ML. Charles PG, et al. Clin Infect Dis. 2009 Jun 15;48(12):1796; author reply 1796-7. doi: 10.1086/599227. Clin Infect Dis. 2009. PMID: 19473089 No abstract available.
A potential "blind spot" in vancomycin treatment studies.
Grayson ML, Charles PG, Howden BP. Grayson ML, et al. Clin Infect Dis. 2012 Jul;55(1):165. doi: 10.1093/cid/cis333. Epub 2012 Mar 29. Clin Infect Dis. 2012. PMID: 22460956 No abstract available.
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
Howden BP, Charles PG, Johnson PD, Ward PB, Grayson ML. Howden BP, et al. Antimicrob Agents Chemother. 2005 Nov;49(11):4816; author reply 4816-7. doi: 10.1128/AAC.49.11.4816-4817.2005. Antimicrob Agents Chemother. 2005. PMID: 16251343 Free PMC article. No abstract available.
Accurate assessment of heterogeneous vancomycin-intermediate Staphylococcus aureus nasal carriage.
Charles PG, Howden BP, Ward PB, Bishop EJ, Johnson PD, Grayson ML. Charles PG, et al. Clin Infect Dis. 2005 Oct 1;41(7):1071-2; author reply 1072-3. doi: 10.1086/444382. Clin Infect Dis. 2005. PMID: 16142682 No abstract available.
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective.
Howden BP, Ward PB, Johnson PD, Charles PG, Grayson ML. Howden BP, et al. Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):100-8. doi: 10.1007/s10096-004-1261-y. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15682283 Review.
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, Grayson ML; Australian CAP Study Collaboration. Charles PG, et al. Clin Infect Dis. 2008 May 15;46(10):1513-21. doi: 10.1086/586749. Clin Infect Dis. 2008. PMID: 18419484 Clinical Trial.
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML. Howden BP, et al. Clin Infect Dis. 2004 Feb 15;38(4):521-8. doi: 10.1086/381202. Epub 2004 Jan 29. Clin Infect Dis. 2004. PMID: 14765345
Rapid molecular determination of methicillin resistance in staphylococcal bacteraemia improves early targeted antibiotic prescribing: a randomized clinical trial.
Emonet S, Charles PG, Harbarth S, Stewardson AJ, Renzi G, Uckay I, Cherkaoui A, Rougemont M, Schrenzel J. Emonet S, et al. Among authors: charles pg. Clin Microbiol Infect. 2016 Nov;22(11):946.e9-946.e15. doi: 10.1016/j.cmi.2016.07.022. Epub 2016 Jul 27. Clin Microbiol Infect. 2016. PMID: 27475737 Free article. Clinical Trial.
53 results
Jump to page
Feedback